ストックスクリーナーアプリを入手
10.82
5.34%
-0.61
前日終値:
$11.43
開ける：
$11.7
24時間の取引高:
2.02M
Relative Volume:
1.30
時価総額：
$621.92M
収益：
$217.11M
当期純損益:
$-651.19M
株価収益率:
-0.8329
EPS:
-12.99
ネットキャッシュフロー:
$-387.26M
1週間 パフォーマンス:
-26.54%
1か月 パフォーマンス:
-6.56%
6か月 パフォーマンス:
+16.22%
1年 パフォーマンス:
-79.03%
1日の値動き範囲:
$10.81
$12.26
1週間の範囲:
$10.81
$15.96
52週間の値動き範囲:
$5.26
$64.40
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
名前
Ginkgo Bioworks Holdings Inc
セクター
電話
(877) 442-5362
住所
27 DRYDOCK AVENUE, BOSTON
DNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
10.82 | 621.92M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-15 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-05-10 | ダウングレード | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-02 | ダウングレード | Goldman | Neutral → Sell |
| 2023-05-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 開始されました | Berenberg | Buy |
| 2022-10-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2022-02-23 | 開始されました | Goldman | Neutral |
| 2022-02-01 | 開始されました | BofA Securities | Neutral |
| 2022-01-28 | 開始されました | BofA Securities | Buy |
| 2022-01-07 | 開始されました | BTIG Research | Buy |
| 2021-11-29 | 開始されました | Jefferies | Buy |
| 2021-10-13 | 開始されました | Raymond James | Outperform |
| 2021-10-12 | 開始されました | William Blair | Outperform |
| 2021-09-20 | 開始されました | HSBC Securities | Buy |
すべてを表示
Ginkgo Bioworks Holdings Inc (DNA) 最新ニュース
Volta Labs enhances Ginkgo Bioworks sequencing workflow By Investing.com - Investing.com Canada
Ginkgo Bioworks Integrates Callisto For Difficult-To-Automate Ngs Processes In Their High-Throughput Lab - Marketscreener.com
Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab - Marketscreener.com
Can This New Lab Automation System Transform Ginkgo's DNA Sequencing Capabilities? - StockTitan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Update - MarketBeat
Ginkgo Bioworks (DNA) to Release Earnings on Tuesday - MarketBeat
Ginkgo Bioworks Partners With HaDEA on Up to $25.1 Million Project for Rapid Virus Diagnostics - Marketscreener.com
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - PR Newswire
Ginkgo Bioworks (NYSE:DNA) Shares Down 6.3%Time to Sell? - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know - MSN
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation - BioSpace
Ginkgo Bioworks Sets Stage for Crucial Q4 Earnings: Here's When to Tune In - StockTitan
Ginkgo Bioworks (NYSE:DNA) Trading 8.8% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 5.4%Here's What Happened - MarketBeat
DNAGinkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series - ADVFN
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Revenues Not Telling The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) After Shares Rise 39% - Simply Wall St
SG Americas Securities LLC Purchases New Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
(DNA) Technical Pivots with Risk Controls - Stock Traders Daily
Ginkgo Bioworks (NYSE:DNA) Trading Up 7.9%What's Next? - MarketBeat
Ginkgo Bioworks CFO Dmytruk sells $9,947 in stock - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Forbes J M & Co. LLP - MarketBeat
Ginko Automation to deploy flexible laboratory automation system at GLBRC - Biodiesel Magazine
Ginkgo Bioworks (NYSE:DNA) Trading Down 6.8%Should You Sell? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Up 7.9%Here's Why - MarketBeat
Ginkgo Bioworks' chief accounting officer sells $4,933 in stock - MSN
Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength? - MSN
Ginkgo Bioworks (NYSE:DNA) Shares Gap DownShould You Sell? - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks' chief accounting officer sells $4,933 in stock By Investing.com - Investing.com Canada
Ginkgo Bioworks CFO Dmytruk sells $9,947 in stock By Investing.com - Investing.com South Africa
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series - Quantisnow
PFG Investments LLC Sells 170,130 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 6.3%Time to Sell? - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Position Trimmed by JPMorgan Chase & Co. - Defense World
Ginkgo Bioworks (NYSE:DNA) Shares Up 9.7%What's Next? - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):